Julian Harrison
Stock Analyst at BTIG
(0)
# 4332
Out of 5,218 analysts
53
Total ratings
38.46%
Success rate
-9.05%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Keros Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 12, 2024 | |
AnaptysBio | Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 2, 2024 | |
Outlook Therapeutics | Maintains: Buy | 50 9 | 1.48 | 508.11% | 5 | Nov 29, 2024 | |
Aclaris Therapeutics | Upgrades: Buy | 8 | 3.23 | 147.68% | 4 | Nov 19, 2024 | |
VYNE Therapeutics | Initiates Coverage On: Buy | 8 | 2.55 | 213.73% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 61 | 17.77 | 243.28% | 3 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | 4.59 | 226.8% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 25 | 10.91 | 129.15% | 3 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 51 | 41.15 | 23.94% | 2 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 43 | 7.15 | 501.4% | 1 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 32 40 | 24.09 | 66.04% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 9.87 | 112.77% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 8 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 43 | 44.27 | -2.87% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 4 | 1.84 | 117.39% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 150 150 | 0.56 | 26685.71% | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 51.39 | -29.95% | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 74 181 | n/a | n/a | 3 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 4 | n/a | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 2 | Feb 11, 2022 |